Example: Heart Attack

Clinical Trials Sponsored by Pevion Biotech Ltd

Total 4 results

NCT01067131

Completed

Safety and Immunogenicity Study of a Virosomal Vaccine Against Recurrent Vulvovaginal Candida Infection

Conditions: Recurrent Vulvovaginal Candidiasis
NCT00445419

Completed

Phase I Hepatitis C Vaccine Trial of Virosome-formulated Peptides

Conditions: Chronic Hepatitis C
NCT00513669

Completed

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Conditions: Falciparum Malaria
NCT00408668

Completed

Efficacy of Combined PEV3A Virosomal Vaccine and FP9-MVA ME-TRAP Prime Boost Regimen

Conditions: Malaria; Malaria, Falciparum